Objective To evaluate the clinical efficacy and safety of L-ornithine-L-aspartate treating the patients with hepatic encephalopathy.
目的 应用门冬氨酸鸟氨酸对肝性脑病的临床疗效及安全性进行观察。
To explore the clinical effectiveness of naloxone and ornithine aspartate in the treatment of the liver cirrhosis and hepatic encephalopathy.
探讨纳洛酮联合门冬氨酸鸟氨酸治疗肝硬化并肝性脑病患者的临床疗效。
Objective: To evaluate the effect and safety of L-ornithine-L-aspartate on Subclinical Hepatic Encephalopathy.
目的：观察门冬氨酸鸟氨酸治疗亚临床肝性脑病的临床疗效及安全性。
Conclusion Naloxone and ornithine aspartate in the treatment of the liver cirrhosis and hepatic encephalopathy was exactly effective.
结论纳洛酮联合门冬氨酸鸟氨酸治疗肝性脑病疗效确切。
Conclusion Naloxone and ornithine aspartate in the treatment of the liver cirrhosis and hepatic encephalopathy was exactly effective.
结论纳洛酮联合门冬氨酸鸟氨酸治疗肝性脑病疗效确切。
应用推荐